MRNA

Moderna, Inc. ·Nasdaq Global Select·Healthcare
63.68 live · 2026-08-12 15:59

Structural scoring is not meaningful for this business

Structural scoring uses gross margin, free cash flow and Altman Z — measures built for operating companies. For banks, insurers and asset managers they produce artifacts, because the cash-flow statement is dominated by lending and deposit flows rather than operations. Treat the structural and composite figures below as not comparable with other sectors, in either direction.

  • Reported free cash flow is far outside the range an operating business can show, indicating balance-sheet rather than operating flows
47.2% not comparable
Brown Bear Score
13.0% not comparable
Business Conviction Score
68.2%
Position Health Score
47.7%
Chase Risk
Daily closes

Daily closes · 1Y (252 sessions) · +148.1% · range 22.36–81.80

The Businesswhat the company reports

Business & cash flow

FCF / assets -16.7%
OCF / assets -15.2%
FCF / revenue -97.5%
Gross margin -66.0%
ROIC -26.6%
Forward P/E -13.2

FCF/assets and OCF/assets are the cash-flow measures Brown Bear's own testing found to survive; FCF/revenue is shown alongside for context. Assets are from the latest annual filing (FY2025).

Price vs Earnings growth

Trailing EPS is negative (-8.39) and forward EPS is not positive, so a growth percentage does not exist

Confidence 35.0/100

Takeaway Low data confidence (limited analyst coverage) — treat this section as informational only.

Reported earnings

Next report 2026-11-04 before the open · consensus EPS -1.22

Q2 23 revenue: 344.00mQ2 23 net income: -1.38bnQ2 23 EPS: -3.62Q3 23 revenue: 1.83bnQ3 23 net income: -3.63bnQ3 23 EPS: -9.53Q3 23Q4 23 revenue: 2.81bnQ4 23 net income: 217.00mQ4 23 EPS: 0.57Q1 24 revenue: 167.00mQ1 24 net income: -1.18bnQ1 24 EPS: -3.08Q1 24Q2 24 revenue: 241.00mQ2 24 net income: -1.28bnQ2 24 EPS: -3.33Q3 24 revenue: 1.86bnQ3 24 net income: 13.00mQ3 24 EPS: 0.03Q3 24Q4 24 revenue: 966.00mQ4 24 net income: -1.12bnQ4 24 EPS: -2.92Q1 25 revenue: 108.00mQ1 25 net income: -971.00mQ1 25 EPS: -2.52Q1 25Q2 25 revenue: 142.00mQ2 25 net income: -825.00mQ2 25 EPS: -2.13Q3 25 revenue: 1.02bnQ3 25 net income: -200.00mQ3 25 EPS: -0.51Q3 25Q4 25 revenue: 678.00mQ4 25 net income: -826.00mQ4 25 EPS: -2.12Q1 26 revenue: 389.00mQ1 26 net income: -1.34bnQ1 26 EPS: -3.40Q1 26

Revenue Net incomeEPS (GAAP) (-9.53–0.57, own scale) Derived Q4

12 quarters to Q1 26. Revenue and net income share one scale, so the gap between them is the margin. The baseline is zero — bars below it are losses. The line is GAAP EPS — it spans every quarter shown, where the reported figure only goes back as far as the consensus feed does.

Quarter endingRevenueYoY Net incomeEPS (GAAP) EPS reportedvs consensus Filed
2026-03-31 389.00m +260.2% -1.34bn -3.40 -3.40 +15.8% 2026-05-01
2025-12-31 (derived) 678.00m -29.8% -826.00m -2.12 -2.11 +21.7% 2026-02-20
2025-09-30 1.02bn -45.4% -200.00m -0.51 -0.51 +76.3% 2025-11-06
2025-06-30 142.00m -41.1% -825.00m -2.13 2025-08-01

Earnings response

Typical move around a filing ±5.3%
On an ordinary two days ±3.2% — filings move it 1.7× as much
Direction 6 up, 5 down over 11 filings
Revenue change and price reaction, by quarter
Q3 22 revenue -32.3% year on yearQ3 22 filed 2022-11-03: price +6.6%Q1 23 revenue -69.3% year on yearQ1 23 filed 2023-05-04: price +5.3%Q1 23Q2 23 revenue -92.8% year on yearQ2 23 filed 2023-08-03: price -1.8%Q3 23 revenue -45.6% year on yearQ3 23 filed 2023-11-03: price +1.2%Q3 23Q1 24 revenue -91.0% year on yearQ1 24 filed 2024-05-02: price +12.1%Q2 24 revenue -29.9% year on yearQ2 24 filed 2024-08-01: price -27.4%Q2 24Q3 24 revenue +1.7% year on yearQ3 24 filed 2024-11-07: price -9.6%Q1 25 revenue -35.3% year on yearQ1 25 filed 2025-05-01: price -3.3%Q1 25Q2 25 revenue -41.1% year on yearQ2 25 filed 2025-08-01: price -6.5%Q3 25 revenue -45.4% year on yearQ3 25 filed 2025-11-06: price +4.2%Q3 25Q1 26 revenue +260.2% year on yearQ1 26 filed 2026-05-01: price +3.0%

Revenue up year on year Revenue down Price move around the filing separate scales — a crossing means nothing

Quarter endingFiledRevenue YoY Move around filingNext 20 sessions vs SPY
2026-03-31 2026-05-01 +260.2% +3.0% -9.3%
2025-09-30 2025-11-06 -45.4% +4.2% +12.1%
2025-06-30 2025-08-01 -41.1% -6.5% -13.9%
2025-03-31 2025-05-01 -35.3% -3.3% -6.6%

Share count

Diluted shares over time

Diluted shares Return since the previous filing

Direction Growing — shares issued
Diluted shares 395.0M as at 2026-03-31
Change over 1 year +2.3%
Change over 3 years -2.5%
Public float $9.90bn as at 2025-06-30 (10-K)

The Pricewhat the chart is doingTop ↑

Price Levels

StrategyCurrent Price Reasonable
Reference band 62.71 — 64.31
Protective stop 54.38 (Atr, 14.4% risk)
Support 53.24 (3 touches, 19.6% away)
Resistance (— away)

Takeaway The shares are about 19.6% above 53.24, a price buyers have stepped in at before. There is no ceiling to point to, because the stock is trading where it has not traded before and nobody has sold it at these levels. That floor has held 3 times, which is how it was spotted. If someone bought at today's price and sold if it dropped through the level below, they would be about 14.4% out of pocket. That is all this figure means — an illustration of the risk, not a price to sell at.

Levels are computed from price structure. They describe where the engine locates support and extension — they are not targets, and not advice.

Ichimoku Cloud (Adaptive)

Daily cloudPrice INSIDE the cloud | periods 7/21/42 (81% of classic 9/26/52)
LinesTenkan/Kijun BEAR | cloud twist BEAR
Cloud thickness98% percentile (thick — substantial structure)
Chikou spanNot clear of price from 26 periods ago
Weekly cloudPrice ABOVE the weekly cloud (context only, not scored)

Takeaway The stock is trading inside its cloud — a shaded band drawn from several of its own moving averages, currently 59.80 to 67.61. Inside the band those averages disagree with each other, so the indicator is not saying much either way. Its shorter-term averages agree with that. The band is unusually wide at the moment, so it marks a broad zone rather than a single level.

Trailing returns

21 days -5.6%
63 days +19.5%
126 days +51.6%
252 days +150.0%
Below 252d high22.2%

Trend context

PositionFar above trend
ExtensionExtremely extended
Trend slopeRising
Direction of travelDiverging from trend

Takeaway Extreme upside extension is still moving away from fair trend; chase risk is elevated.

Volatility

State No recent compression
Current band width20.5% of price
Recent tightest20.5% (0 sessions ago, narrower than 65.0% of its history)
Expansion since1.00×
Band 51.93 — 63.81

Takeaway Lately this share price has been swinging around inside a range roughly 21% wide. That is normal for this stock, so there is nothing unusual to read into it either way.

Historical trends

0255075100Share price 53.86–81.802026-07-032026-08-12
Position Health Business Conviction Share price

History begins when the site started recording, not when the company listed, so a short line means a short record and nothing more.

Who's Tradingthe flow behind the priceTop ↑

Insider activity

ActivityNo filings in the window
Buy filings0
Sell filings0

Open-market Form 4 purchases and sales over the last 75 days, read from SEC EDGAR Form 4. Grants, option exercises, gifts and shares withheld for tax are excluded — they are compensation mechanics, not a decision to buy or sell. Reported Form 4 activity. Brown Bear tested insider cluster-buying as a return signal and rejected it as era-unstable; shown as fact, not signal.

Volume confirmation

Volume-price trend Above its signal line
Confirmation Marginal

No absorption or distribution event in the recent window.

Takeaway Slightly more shares change hands on rising days than on falling ones, but the gap is too small to read anything into.

Options Positioning

No binary-event flag

MRNA: no binary-event flag. Near IV 69%, far IV 77% (ratio 0.90), implied move 8.6%.

Implied volatility 69% near (9d) · 77% far (65d)
Term structure 0.90× near/far
Historical volatility 68%
Implied vs historical 1.01×
Implied move ±8.6% by 2026-08-21
Implied move vs ATR 0.50×
Skew Flat (1.00×)
Call wall 65.00 (+2.1% away)
Put wall 55.00 (-13.6% away)
Gamma pin 55.00

Takeaway Insuring against a move in this stock costs less for the next few weeks than for the next few months, which is the normal state of affairs and suggests no particular date is worrying anyone. Options traders are positioned for a move of around 8.6% in either direction by 2026-08-21.

Chain as at 2026-08-12. This is a risk read on whether a specific event is being priced — not a directional view.

Context & Methodthe record, and how it was builtTop ↑

Relative Rotation

ImprovingLeadingLaggingWeakeningvs sectorvs SPYsector vs SPYRS-Ratio →RS-Momentum →

Early Stock Rotation

Rotation health 73.4/100; Positive Rotation.

Rotation health 73.4
Rotation strength 68.9
LegQuadrantRS-RatioRS-Mom
Stock vs sector Improving 95.0 118.6
Stock vs SPY Improving 94.2 118.6
Sector vs SPY Improving 86.4 102.1

Direction of travel: North-East / strengthening leadership

Position only. Brown Bear's RRG redesign programme is closed — five constructions, none beat an appropriate null — so this section describes where the name sits, and is not a signal.

News Headlines

  1. Loading headlines\u2026

Headlines are supplied by third-party feeds and are not written, ranked or interpreted by Brown Bear. They feed no score on this page.

Detailed Scoring

Positive signals

  • Altman Z-score 8.69 (+6.0)
  • Insider conviction score (+5.0)
  • FCF margin improving by -3.5 pts (+-1.0)
  • High earnings quality (accrual ratio -0.077) (+2.0)
  • Accrual ratio improving (-0.04 -> -0.08) (+2.0)
  • Track 2: MACD histogram state (0.68) (+8.0)
  • Track 2: MACD line/signal trend quality (+18.0)
  • Track 2: MACD slope expanding (+5.0)
  • Track 2: volume expansion 1.10x average (+0.5)
  • Track 2: relative strength trend improving (+10.0)
  • Track 2: bullish DI spread 5.6 (+3.0)
  • Track 2: ADX 54.6 and flat (+15.0)
  • Track 2: relative momentum rank 0.96 (+15.0)
  • Track 2: Bullish MACD divergence (+4.0)
  • Track 2: price above EMA20 by 7.3% (+6.1)
  • Track 2: EMA20 slope expanding 0.5% (+1.4)
  • Track 2: MACD histogram acceleration 1.36 (+12.0)
  • Track 2: RSI trend quality 62.0, 5-day change +27.8 (+12.0)
  • Track 2: VPT strength 0.03 (+0.7)
  • Track 2: price above EMA50 by 8.2% (+6.6)
  • Track 2: Bollinger position 0.99 (+7.9)

Negative signals

  • Track 2: negative MACD regime (-8.0)
  • Track 2: negative 20-day momentum acceleration (-0.38)
  • Track 2: EMA50 slope deteriorating -0.6%
  • Chase risk 47.7/100 (Elevated Chase Risk): RSI 62.0, EMA20 7.3%, EMA50 8.2%, BB 0.99, distribution 2.0/100
  • Weak Piotroski F-score (2/9)
  • Gross margin improving by -120.3 pts (+-1.0)
  • Track 2 structural exemption: structural score 3.0/100 below the 25 quality floor; this is an unowned speculative candidate, so the universal SELL gate was skipped and the Track 2 momentum/RRG grid was allowed to evaluate instead. Structural quality here is weak by design for this kind of candidate -- treat any resulting BUY as higher risk than a Track 1 signal.
  • Chase risk 47.7/100 | Extension score 52.3/100 | Elevated Chase Risk